BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pérez-Lloret S, Cardinali DP. Melatonin as a Chronobiotic and Cytoprotective Agent in Parkinson's Disease. Front Pharmacol 2021;12:650597. [PMID: 33935759 DOI: 10.3389/fphar.2021.650597] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Cardinali DP, Brown GM, Pandi-Perumal SR. Melatonin's Benefits and Risks as a Therapy for Sleep Disturbances in the Elderly: Current Insights. Nat Sci Sleep 2022;14:1843-55. [PMID: 36267165 DOI: 10.2147/NSS.S380465] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Yang J, Tang Q, Zeng Y. Melatonin: Potential avenue for treating iron overload disorders. Ageing Res Rev 2022;81:101717. [PMID: 35961513 DOI: 10.1016/j.arr.2022.101717] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Martín Giménez VM, de las Heras N, Lahera V, Tresguerres JAF, Reiter RJ, Manucha W. Melatonin as an Anti-Aging Therapy for Age-Related Cardiovascular and Neurodegenerative Diseases. Front Aging Neurosci 2022;14:888292. [DOI: 10.3389/fnagi.2022.888292] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Reiter RJ, Sharma R, Rosales-corral S, de Mange J, Phillips WT, Tan DX, Bitar RD. Melatonin in ventricular and subarachnoid cerebrospinal fluid: Its function in the neural glymphatic network and biological significance for neurocognitive health. Biochemical and Biophysical Research Communications 2022;605:70-81. [DOI: 10.1016/j.bbrc.2022.03.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
5 Duarte P, Michalska P, Crisman E, Cuadrado A, León R. Novel Series of Dual NRF2 Inducers and Selective MAO-B Inhibitors for the Treatment of Parkinson’s Disease. Antioxidants 2022;11:247. [DOI: 10.3390/antiox11020247] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Hunt J, Coulson EJ, Rajnarayanan R, Oster H, Videnovic A, Rawashdeh O. Sleep and circadian rhythms in Parkinson's disease and preclinical models. Mol Neurodegener 2022;17:2. [PMID: 35000606 DOI: 10.1186/s13024-021-00504-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Plano SA, Demaría Pesce V, Cardinali DP, Vigo DE. Melatonin: A Promising Drug to Ameliorate Main Human Space Exploration Risks. Handbook of Space Pharmaceuticals 2022. [DOI: 10.1007/978-3-319-50909-9_56-1] [Reference Citation Analysis]
8 Plano SA, Demaría Pesce V, Cardinali DP, Vigo DE. Melatonin: A Promising Drug to Ameliorate Main Human Space Exploration Risks. Handbook of Space Pharmaceuticals 2022. [DOI: 10.1007/978-3-030-05526-4_56] [Reference Citation Analysis]
9 Fishbein AB, Knutson KL, Zee PC. Circadian disruption and human health. J Clin Invest 2021;131:e148286. [PMID: 34596053 DOI: 10.1172/JCI148286] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 12.0] [Reference Citation Analysis]
10 Yang S, Wan Y, Wu N, Song L, Liu Z, Zhao J, Liu Y, Liu Z, Gan J. L-3,4-Dihydroxyphenylalanine Recovers Circadian Rhythm Disturbances in the Rat Models of Parkinson's Disease by Regulating the D1R-ERK1/2-mTOR Pathway. Front Aging Neurosci 2021;13:719885. [PMID: 34489685 DOI: 10.3389/fnagi.2021.719885] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Yan J, Liu A, Huang J, Wu J, Shen R, Ma H, Yang J. Pharmacological Interventions for REM Sleep Behavior Disorder in Parkinson's Disease: A Systematic Review. Front Aging Neurosci 2021;13:709878. [PMID: 34483882 DOI: 10.3389/fnagi.2021.709878] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Koop S, Oster H. Eat, sleep, repeat - endocrine regulation of behavioural circadian rhythms. FEBS J 2021. [PMID: 34228879 DOI: 10.1111/febs.16109] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]